chr6-118481910-A-AT
Position:
Variant summary
Our verdict is Likely pathogenic. Variant got 7 ACMG points: 8P and 1B. PVS1BS2_Supporting
The NM_001042475.3(CEP85L):c.1613dupA(p.Asn538fs) variant causes a frameshift change. The variant allele was found at a frequency of 0.00000384 in 1,563,058 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★). Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: 𝑓 0.0000067 ( 0 hom., cov: 31)
Exomes 𝑓: 0.0000035 ( 0 hom. )
Consequence
CEP85L
NM_001042475.3 frameshift
NM_001042475.3 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 4.12
Genes affected
CEP85L (HGNC:21638): (centrosomal protein 85 like) The protein encoded by this gene was identified as a breast cancer antigen. Nothing more is known of its function at this time. Three transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, May 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_pathogenic. Variant got 7 ACMG points.
PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
BS2
High AC in GnomAdExome4 at 5 AD gene. Variant has AC lower than other variant known as pathogenic in the gene, so the strength is limited to Supporting.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CEP85L | NM_001042475.3 | c.1613dupA | p.Asn538fs | frameshift_variant | 8/13 | ENST00000368491.8 | NP_001035940.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CEP85L | ENST00000368491.8 | c.1613dupA | p.Asn538fs | frameshift_variant | 8/13 | 1 | NM_001042475.3 | ENSP00000357477.3 | ||
CEP85L | ENST00000434604.5 | c.1622dupA | p.Asn541fs | frameshift_variant | 9/9 | 1 | ENSP00000392131.1 | |||
CEP85L | ENST00000368488.9 | c.1622dupA | p.Asn541fs | frameshift_variant | 9/14 | 5 | ENSP00000357474.5 |
Frequencies
GnomAD3 genomes AF: 0.00000666 AC: 1AN: 150204Hom.: 0 Cov.: 31
GnomAD3 genomes
AF:
AC:
1
AN:
150204
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.00000354 AC: 5AN: 1412854Hom.: 0 Cov.: 28 AF XY: 0.00000142 AC XY: 1AN XY: 701944
GnomAD4 exome
AF:
AC:
5
AN:
1412854
Hom.:
Cov.:
28
AF XY:
AC XY:
1
AN XY:
701944
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00000666 AC: 1AN: 150204Hom.: 0 Cov.: 31 AF XY: 0.0000137 AC XY: 1AN XY: 73200
GnomAD4 genome
AF:
AC:
1
AN:
150204
Hom.:
Cov.:
31
AF XY:
AC XY:
1
AN XY:
73200
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Jan 16, 2024 | Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene or region of a gene for which loss of function is not a well-established mechanism of disease; Has not been previously published as pathogenic or benign to our knowledge - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at